BackNeuroSense Therapeutics Overview

NeuroSense Therapeutics Common Stock

Latest common stock for NRSN: $0.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$0.00

Peer trimmed avg / median

Loading

NeuroSense Therapeutics Common Stock History

Loading

NeuroSense Therapeutics vs. peers: Common Stock Comparison

Loading

NeuroSense Therapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

NeuroSense Therapeutics (NRSN) FAQ

As of the most recent data (December 2025), NRSN shows a common stock of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRSN's common stock is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether NeuroSense Therapeutics is outperforming or lagging.

Tracking NRSN's common stock over time shows whether NeuroSense Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has NeuroSense Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $0) with ownership activity and broader fundamentals.